APA (7th ed.) Citation

R, S., DKA, C., JJ, Z., ARYB, L., G, K., HL, T., . . . JBY, S. (2024). Phase I PIANO trial-PIPAC-oxaliplatin and systemic nivolumab combination for gastric cancer peritoneal metastases: Clinical and translational outcomes. ESMO open, 9(9), 103681. https://doi.org/10.1016/j.esmoop.2024.103681

Chicago Style (17th ed.) Citation

R, Sundar, et al. "Phase I PIANO Trial-PIPAC-oxaliplatin and Systemic Nivolumab Combination for Gastric Cancer Peritoneal Metastases: Clinical and Translational Outcomes." ESMO Open 9, no. 9 (2024): 103681. https://doi.org/10.1016/j.esmoop.2024.103681.

MLA (9th ed.) Citation

R, Sundar, et al. "Phase I PIANO Trial-PIPAC-oxaliplatin and Systemic Nivolumab Combination for Gastric Cancer Peritoneal Metastases: Clinical and Translational Outcomes." ESMO Open, vol. 9, no. 9, 2024, p. 103681, https://doi.org/10.1016/j.esmoop.2024.103681.